Medpace Holdings (MEDP) EBT Margin (2015 - 2026)
Medpace Holdings (MEDP) reported EBT Margin of 20.89% for Q1 2026, down 27.0% on a YoY basis from 28.61% in Q1 2025, and down 5.65% quarter-over-quarter from 22.14% in Q4 2025.
Medpace Holdings (MEDP) EBT Margin (2015 - 2026) Analysis & Trends
Medpace Holdings has reported EBT Margin for 12 years, with the latest figure at 20.89% in Q1 2026.
- For the quarter ending Q1 2026, EBT Margin fell 27.0% year-over-year to 20.89%; the trailing twelve-month figure through Mar 2026 stood at 21.35% (down 97.0% YoY), and the FY2025 full-year result was 21.44%, down 113.0% from the prior year.
- EBT Margin for Q1 2026 stood at 20.89%, down from 22.14% in the prior quarter.
- The five-year high for EBT Margin was 24.95% in Q4 2024, with the low at 16.44% in Q2 2023.
- Historically, EBT Margin has averaged 20.32% across 5 years, with a median of 20.89% in 2026.
- Annual changes were most pronounced in 2023 — EBT Margin slumped 445 bps — and 2024, when it surged 675 bps.
- Medpace Holdings' EBT Margin stood at 18.69% in 2022, then fell by 3 bps to 18.2% in 2023, then soared by 37 bps to 24.95% in 2024, then fell by 11 bps to 22.14% in 2025, then retreated by 6 bps to 20.89% in 2026.
- The last three EBT Margin figures came in at 20.89% (Q1 2026), 22.14% (Q4 2025), and 21.64% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -6.95% |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 15.76% |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 20.75% |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 31.16% |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 22.23% |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 7.90% |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | -12.17% |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | 14.39% |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | 22.14% |
| 10 | Medpace Holdings | 13.03 Bn | 12.38 Bn | 196.33 Mn | 20.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.89% |
| Dec 31, 2025 | 22.14% |
| Sep 30, 2025 | 21.64% |
| Jun 30, 2025 | 20.64% |
| Mar 31, 2025 | 21.16% |
| Dec 31, 2024 | 24.95% |
| Sep 30, 2024 | 22.27% |
| Jun 30, 2024 | 20.92% |
| Mar 31, 2024 | 22.07% |
| Dec 31, 2023 | 18.20% |
| Sep 30, 2023 | 16.89% |
| Jun 30, 2023 | 16.44% |
| Mar 31, 2023 | 19.82% |
| Dec 31, 2022 | 18.69% |
| Sep 30, 2022 | 21.34% |
| Jun 30, 2022 | 17.65% |
| Mar 31, 2022 | 19.74% |
| Dec 31, 2021 | 18.12% |
| Sep 30, 2021 | 18.52% |
| Jun 30, 2021 | 15.34% |